The effect of Sprotte and Quincke spinal needles on the frequency and severity of neurological syndrome. Other complications of spinal and epidural anesthesia during labor and delivery
Conditions
Interventions
Intervention 1: Intervention group: The patients of this group (n=80) using of Sprotte( manufacturer: B brown) spinal needle G25 undergoing spinal anesthesia. Intervention 2: Control group: The patie
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Candidate for elective cesarean delivery Candidate for spinal anesthesia Patients between 18-40 years ASA Class I&II Term and singleton pregnancy
Exclusion criteria
Exclusion criteria: Weight over 100 kg and height less than 150 cm Allergy to local anesthetics medicines History of psychiatric disease Spinal cord stenosis and lumbar discopathy History of systemic diseases (cardiovascular, hepatic, pulmonary, ...)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of onset of symptoms of transient neurological syndrome. Timepoint: 6 to 48 hours after surgery. Method of measurement: Physical examination.;Duration of symptoms of transient neurological syndrome after recovery from anesthesia. Timepoint: 6 to 48 hours after surgery. Method of measurement: Physical examination.;Severity of pain caused by transient neurological syndrome. Timepoint: 6 to 48 hours after surgery. Method of measurement: Similar verbal scoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of treatment used for transient neurological syndrome. Timepoint: 6 to 48 hours after surgery. Method of measurement: Clinical record.;The dose of treatment used to treat transient neurological syndrome. Timepoint: 6 to 48 hours after surgery. Method of measurement: Clinical record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Simin Atashkhoyi
Tabriz University of Medical Sciences
Outcome results
None listed